BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20660384)

  • 1. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.
    Vos FJ; Bleeker-Rovers CP; Sturm PD; Krabbe PF; van Dijk AP; Cuijpers ML; Adang EM; Wanten GJ; Kullberg BJ; Oyen WJ
    J Nucl Med; 2010 Aug; 51(8):1234-40. PubMed ID: 20660384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.
    Vos FJ; Kullberg BJ; Sturm PD; Krabbe PFM; van Dijk APJ; Wanten GJA; Oyen WJG; Bleeker-Rovers CP
    Medicine (Baltimore); 2012 Mar; 91(2):86-94. PubMed ID: 22391470
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Berrevoets MAH; Kouijzer IJE; Aarntzen EHJG; Janssen MJR; De Geus-Oei LF; Wertheim HFL; Kullberg BJ; Oever JT; Oyen WJG; Bleeker-Rovers CP
    J Nucl Med; 2017 Sep; 58(9):1504-1510. PubMed ID: 28336786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia.
    Vos FJ; Bleeker-Rovers CP; Kullberg BJ; Adang EM; Oyen WJ
    J Nucl Med; 2011 Nov; 52(11):1673-8. PubMed ID: 21984799
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
    J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septic pulmonary emboli detected by
    Méndez-Echevarria A; Coronado-Poggio M; Baquero-Artigao F; Del Rosal T; Rodado-Marina S; Calvo C; Domínguez-Gadea L
    Infection; 2017 Oct; 45(5):691-696. PubMed ID: 28243995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis.
    Kouijzer IJ; Vos FJ; Janssen MJ; van Dijk AP; Oyen WJ; Bleeker-Rovers CP
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1102-7. PubMed ID: 23471580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.
    Brøndserud MB; Pedersen C; Rosenvinge FS; Høilund-Carlsen PF; Hess S
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1351-1358. PubMed ID: 30788532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-Head Comparison of
    Salomäki SP; Kemppainen J; Hohenthal U; Luoto P; Eskola O; Nuutila P; Seppänen M; Pirilä L; Oksi J; Roivainen A
    Contrast Media Mol Imaging; 2017; 2017():3179607. PubMed ID: 29114175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET in detecting metastatic infectious disease.
    Bleeker-Rovers CP; Vos FJ; Wanten GJ; van der Meer JW; Corstens FH; Kullberg BJ; Oyen WJ
    J Nucl Med; 2005 Dec; 46(12):2014-9. PubMed ID: 16330565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of
    Suanzes P; Willekens R; Puig-Asensio M; Pizzi MN; Roque A; Barios M; Simó M; Rodríguez-Pardo D; Larrosa MN; Fernández-Hidalgo N; Almirante B
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):3-10. PubMed ID: 36319538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of FDG-PET/CT in metastatic infections.
    Kouijzer IJ; Vos FJ; Bleeker-Rovers CP; Oyen WJ
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):232-246. PubMed ID: 26883515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Antibiotic Treatment Affect the Diagnostic Accuracy of
    Kagna O; Kurash M; Ghanem-Zoubi N; Keidar Z; Israel O
    J Nucl Med; 2017 Nov; 58(11):1827-1830. PubMed ID: 28473596
    [No Abstract]   [Full Text] [Related]  

  • 14. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C; Lépine M; Verreault J; Bénard F
    J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of [
    Gompelman M; Tuinte R; Aarntzen E; Kouijzer I; van Leerdam E; Berrevoets M; Ten Oever J; Bleeker-Rovers C; Wanten G
    Biomed Pharmacother; 2021 Dec; 144():112296. PubMed ID: 34634557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT in Detecting Metastatic Infection in Children.
    Kouijzer IJ; Blokhuis GJ; Draaisma JM; Oyen WJ; de Geus-Oei LF; Bleeker-Rovers CP
    Clin Nucl Med; 2016 Apr; 41(4):278-81. PubMed ID: 26825207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.